How we help clients
Bringing cutting edge capabilities in design, digital and analytics to create innovative products, devices, equipment, software, and solutions that enhance patient value and outcomes.
Using our operations expertise to drive performance, increase revenue, and enhance the bottom line.
Helping to optimize, reinvent and improve supply chains for companies through pharmaceutical, biotechnological industries, NGS, and medical devices.
Research & Development
Helping clients build the R&D capabilities needed to drive innovation, improve productivity and performance, and develop successful portfolio and asset strategies.
Helping clients to transform their medical affairs function into the company’s third strategic pillar alongside R&D and commercial.
Commercial & Valuation
Helping clients maximize company value by assisting with product launch, marketing, sales, and market access.
Precision medicine in practice: strategies for rare cancers.
The small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions.
Winning against Covid-19: The implications for biopharma
How companies act individually and collectively in the coming weeks and months will result in the result of the pandemic.
The promise of digital therapeutics.
Investments in digital-therapeutic companies in the United States have grown, on average, by 40 percent per year.
The Diploid Consulting Cancer Center helps life science organizations discover, develop and distribute more effective medications, offer better care and provide broader access to solutions that help patients and their families fight cancer .